|
| Parameter | Healthy subjects | Pseudomonas aeruginosa | Staphylococcus aureus |
|
| Demographics | | | |
| | 11 | 12 | 10 |
| Sex (men/women) | 5/6 | 3/9 | 3/7 |
| Age at enrollment (y) | | | |
| Height (m) | | | |
| Weight (kg) | | | |
| Body mass index (kg/m2) | | | |
| Genetics | | | |
| ΔF508/ΔF508 | — | 8 | 1 |
| Unknown | — | 0 | 3 |
| Clinical hematologic variables | | | |
| WBC (×103 cells/L) (reference range, 5.5–15.5) | | | |
| RBC (×106 cells/L) (reference range, 3.7–5.3) | | | |
| Neutrophil ((×103 cells/L) (reference range, 1.8–8) | | | |
| Lymphocyte (%) (reference range, 25–50) | | | |
| Monocyte (%) (reference range, 0–11) | | | |
| Eosinophil (%) (reference range, 1–5) | | | |
| Basophil (%) (reference range, 0–1.5) | | | |
| HCT (%) (reference range, 35–45) | | | |
| MCV (fL) (reference range, 76–90) | | | |
| Hb (g/dL) (reference range, 11.5–14.5) | | | |
| Serum biochemical parameters | | | |
| C-reactive protein (mg/L) (reference range, 0–10) | | | |
| Protein (g/dL) (reference range, 6–8) | | | |
| Bilirubin (mol/L) (reference range, 0–17.1) | | | |
| Glucose (mmol/L)) (reference range, 3.6–6.1) | | | |
| Aspartate transaminase(AST) (U/L) (reference range, 1–35) | | | |
| Alanine aminotransferase(ALAT) (U/L) (reference range, 1–34) | | | |
| Gamma-glutamyltransferase (GGTP) (U/L) (reference range, 1–36) | | | |
| Alkaline phosphatase(ALP) (U/L) (reference range, 110–369) | | | |
| Cholesterol (mg/dL) (reference range, 0–200) | | | |
| High-density lipoprotein (mg/dL) (reference range, 0–40) | | | |
| Low-density lipoprotein (mg/dL) (reference range, 0–180) | | | |
| Triglycerides (mg/dL) (reference range, 60–160) | | | |
| Sodium (mmol/L) (reference range, 135–145) | | | |
| Potassium (mmol/L, reference range, 3.5–5) | | | |
| Urea (mmol/L) (reference range, 2.5–6.7) | | | |
| Creatinine (mol/L) (reference range, 60–130) | | | |
| Pulmonary function | | | |
| FEV1 (% predicted) | | | |
| FEV1/FVC (%) | | | |
|
